Page last updated: 2024-10-31

metoclopramide and Sarcoma

metoclopramide has been researched along with Sarcoma in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.

Research Excerpts

ExcerptRelevanceReference
" Regimen B, employing a lower dosage of metoclopramide and steroids and using a more simple schedule of administration should be the preferred treatment."2.67Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients. ( Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roila, F1
Bracarda, S1
Basurto, C1
Sassi, M1
Lupattelli, M1
Picciafuoco, M1
Boschetti, E1
Del Favero, A1
Tonato, M1

Trials

1 trial available for metoclopramide and Sarcoma

ArticleYear
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
    American journal of clinical oncology, 1992, Volume: 15, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double-

1992